![]() |
市场调查报告书
商品编码
1900735
神经科设备市场规模、份额和成长分析(按产品类型、最终用户和地区划分)-2026-2033年产业预测Neurology Devices Market Size, Share, and Growth Analysis, By Product Type (Neurostimulation, Interventional Neurology), By End User (Hospitals, Ambulatory Surgery Centers), By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年,全球神经科设备市场规模将达到 170.4 亿美元,到 2025 年将达到 184.2 亿美元,到 2033 年将达到 343.5 亿美元,预测期(2026-2033 年)的复合年增长率为 8.1%。
全球神经系统疾病器材市场预计将迎来显着成长,这主要得益于神经系统疾病盛行率的上升、私部门投资的增加以及神经治疗研发的进步。阿兹海默症、帕金森氏症和癫痫等疾病的发病率不断攀升,尤其是在老龄化人口中,这推动了对创新诊断和治疗器械的需求。此外,神经系统疾病和心血管疾病的快速增长、公众意识的提高以及微创手术的趋势,也促进了对神经血管器械的需求。然而,高成本、监管严格、发展中地区准入受限以及併发症风险等挑战,可能会阻碍市场的长期成长和普及。
全球神经病学器材市场驱动因素
不良生活方式和不健康习惯导致的神经血管疾病日益增多,显着推动了对神经血管器械的需求。中风和脑动脉瘤等疾病的发生率不断上升,进一步刺激了市场需求。此外,全球人口老化也是造成此趋势的重要因素,因为老年人更容易患上阿兹海默症、帕金森氏症和失智症神经系统疾病和神经退化性疾病。这种人口结构变化在北美、欧洲和亚洲部分地区尤为显着,医疗保健系统面临越来越大的挑战,需要提供有效的诊断和神经系统服务,以满足这些弱势群体日益增长的需求。
限制全球神经科设备市场的因素
由于先进的神经血管装置运用了创新医疗技术,其高成本对全球神经科器械市场构成了重大挑战。已开发国家或许能够负担这些费用,但发展中国家的医疗机构往往面临预算限制,阻碍了他们取得这些装置。此外,缺乏操作这些先进技术和解读结果的专业培训,也为有效的神经科治疗带来了额外的障碍。许多医疗资源匮乏地区的医疗机构缺乏整合这些创新技术所需的资源,这凸显了迫切需要经济有效的解决方案和加强培训倡议,以提高医疗服务的可及性和改善患者预后。
全球神经病学设备市场趋势
全球神经科设备市场正经历显着的发展趋势,而这主要得益于神经刺激技术的进步。旨在向特定脑区和神经传递电脉衝的设备正在改变慢性疼痛、癫痫、帕金森氏症和失智症疾病的治疗格局。诸如深部脑部刺激(DBS)和脊髓刺激设备(SCS)等创新技术正日益受到关注,因为它们提供了一种微创替代方案,既能缓解症状,又能提高患者的生活品质。对具有更高精度、更强连接性和更长电池续航时间的神经刺激设备的需求不断增长,反映出患者和医疗专业人员对先进治疗方案的日益青睐。
Global Neurology Devices Market size was valued at USD 17.04 Billion in 2024 and is poised to grow from USD 18.42 Billion in 2025 to USD 34.35 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).
The global neurology devices market is poised for significant growth, driven by the rising prevalence of neurological disorders, increasing investments from private sectors, and advancements in neurotherapy research and development. The escalating need for innovative diagnostic and therapeutic devices stems from the growing incidence of conditions such as Alzheimer's, Parkinson's, and epilepsy, particularly among the aging population, which faces a higher risk of such ailments. Additionally, the demand for neurovascular devices is buoyed by a surge in neurological and cardiovascular conditions, heightened awareness, and the trend towards minimally invasive procedures. However, challenges like the high cost of devices, stringent regulations, limited access in developing regions, and the risk of complications may hinder long-term market growth and accessibility.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Neurology Devices Market Segments Analysis
Global Neurology Devices Market is segmented by Product Type, End User and region. Based on Product Type, the market is segmented into Neurostimulation, Interventional Neurology, CSF Management Devices and Neurosurgery Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Neurology Devices Market
The rise in neurovascular diseases, attributed to poor lifestyle choices and unhealthy habits, has led to a marked increase in the need for neurovascular devices. Conditions such as strokes and cerebral aneurysms are becoming more prevalent, driving demand in the market. Additionally, the global aging population is contributing significantly to this trend, as older individuals are more susceptible to neurological and neurodegenerative diseases, including Alzheimer's, Parkinson's, and dementia. This demographic transformation is particularly noticeable in regions like North America, Europe, and parts of Asia, where healthcare systems are increasingly challenged to provide effective diagnostic and neurological services to meet the growing needs of this vulnerable population.
Restraints in the Global Neurology Devices Market
The Global Neurology Devices market faces significant challenges due to the high costs associated with advanced neurovascular devices, which utilize innovative medical technologies. While these expenses may be manageable for developed nations, healthcare facilities in developing regions often contend with constrained budgets, hindering their access to such devices. Additionally, a shortage of specialized training for operating these advanced technologies and interpreting their results poses further obstacles to effective neurological care. Many healthcare providers in underserved locations lack the necessary resources to integrate these innovations, underscoring the urgent requirement for cost-effective solutions and enhanced training initiatives to improve accessibility and patient outcomes.
Market Trends of the Global Neurology Devices Market
The Global Neurology Devices market is witnessing a significant trend driven by advancements in neurostimulation technology. Devices designed to deliver electrical impulses to targeted brain areas or nerves are transforming the treatment landscape for conditions like chronic pain, epilepsy, Parkinson's disease, and dementia. Innovations such as deep brain stimulation (DBS) and spinal cord stimulators (SCS) are gaining traction due to their ability to alleviate symptoms and enhance patients' quality of life while offering minimally invasive alternatives. Increasing demand for neurostimulation devices boasting enhanced precision, connectivity, and improved battery life reflects the growing preference among patients and healthcare professionals for advanced therapeutic solutions.